Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-011523
Filing Date
2023-07-27
Accepted
2023-07-27 16:21:04
Documents
1
Period of Report
2023-07-27

Document Format Files

Seq Description Document Type Size
1 form4-07272023_080751.html 4  
1 form4-07272023_080751.xml 4 6017
  Complete submission text file 0001415889-23-011523.txt   7401
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET, SUITE 600 CAMBRIDGE MA 02142
Business Address
Yuan Qing Sarah (Reporting) CIK: 0001907487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 231118705